Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (521-530 of 930) with videos related to

Pageof 93
Sort By:
Ejhaem|December 5, 2022
Impact of ixazomib-lenalidomide-dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging-markets subgroup of the TOURMALINE-MM1 trialAndrew Spencer, Olga Samoilova, Wee-Joo Chng, et al.
Ejhaem|July 6, 2021
Lessons learnt from COVID-19 coagulopathyJecko Thachil
Ejhaem|July 6, 2021
Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipientsPatrice Chevallier, Marianne Coste-Burel, Amandine Le Bourgeois, et al.
Ejhaem|December 28, 2020
Plasma exchange for COVID-19 thrombo-inflammatory diseaseNishkantha Arulkumaran, Mari Thomas, David Brealey, et al.
Ejhaem|May 23, 2022
Immune thrombocytopenia management during COVID-19 pandemic: An Italian monocentric experienceGianfranco Lapietra, Antonietta Ferretti, Erminia Baldacci, et al.
Ejhaem|March 11, 2021
Increased body mass index is a risk factor for acute promyelocytic leukemiaSarah M Kashanian, Andrew Y Li, Moaath Mustafa Ali, et al.
Ejhaem|July 18, 2022
CAR T cell therapy in solid tumors: A review of current clinical trialsUrvi Patel, John Abernathy, Bipin N Savani, et al.
Ejhaem|July 18, 2022
Real-world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000-2014, focusing on patients aged >60 yearsBjörn Engelbrekt Wahlin, Ninja Övergaard, Stefan Peterson, et al.
Ejhaem|July 18, 2022
Efficacy and tolerability of a modified pediatric-inspired intensive regimen for acute lymphoblastic leukemia in older adultsAnand Ashwin Patel, Joseph Heng, Emily Dworkin, et al.
Ejhaem|July 18, 2022
Patient risk stratification and tailored clinical management of post-transplant CMV-, EBV-, and BKV-infections by monitoring virus-specific T-cell immunityAnastasia Papadopoulou, Kiriakos Koukoulias, Maria Alvanou, et al.
Pageof 93

Showing results (521-530 of 930) with videos related to

Sort By:
Pageof 93
Ejhaem|December 5, 2022
Impact of ixazomib-lenalidomide-dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging-markets subgroup of the TOURMALINE-MM1 trialAndrew Spencer, Olga Samoilova, Wee-Joo Chng, et al.
Ejhaem|July 6, 2021
Lessons learnt from COVID-19 coagulopathyJecko Thachil
Ejhaem|July 6, 2021
Safety and immunogenicity of a first dose of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic stem-cells recipientsPatrice Chevallier, Marianne Coste-Burel, Amandine Le Bourgeois, et al.
Ejhaem|December 28, 2020
Plasma exchange for COVID-19 thrombo-inflammatory diseaseNishkantha Arulkumaran, Mari Thomas, David Brealey, et al.
Ejhaem|May 23, 2022
Immune thrombocytopenia management during COVID-19 pandemic: An Italian monocentric experienceGianfranco Lapietra, Antonietta Ferretti, Erminia Baldacci, et al.
Ejhaem|March 11, 2021
Increased body mass index is a risk factor for acute promyelocytic leukemiaSarah M Kashanian, Andrew Y Li, Moaath Mustafa Ali, et al.
Ejhaem|July 18, 2022
CAR T cell therapy in solid tumors: A review of current clinical trialsUrvi Patel, John Abernathy, Bipin N Savani, et al.
Ejhaem|July 18, 2022
Real-world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000-2014, focusing on patients aged >60 yearsBjörn Engelbrekt Wahlin, Ninja Övergaard, Stefan Peterson, et al.
Ejhaem|July 18, 2022
Efficacy and tolerability of a modified pediatric-inspired intensive regimen for acute lymphoblastic leukemia in older adultsAnand Ashwin Patel, Joseph Heng, Emily Dworkin, et al.
Ejhaem|July 18, 2022
Patient risk stratification and tailored clinical management of post-transplant CMV-, EBV-, and BKV-infections by monitoring virus-specific T-cell immunityAnastasia Papadopoulou, Kiriakos Koukoulias, Maria Alvanou, et al.
Pageof 93